Mersana Therapeutics Correlations

MRSN Stock

USD 2.21 0.31 12.30%

The current 90-days correlation between Mersana Therapeutics and Terns Pharmaceuticals is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mersana Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mersana Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Mersana Therapeutics Correlation With Market

Very weak diversification

The correlation between Mersana Therapeutics and DJI is 0.55 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mersana Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mersana Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Mersana Stock, please use our How to Invest in Mersana Therapeutics guide.

Moving together with Mersana Stock

0.65	DMAC	DiaMedica Therapeutics	Pair Corr
0.79	DNLI	Denali Therapeutics	Pair Corr
0.82	VCYT	Veracyte	Pair Corr
0.7	VERA	Vera Therapeutics	Pair Corr
0.75	DSGN	Design Therapeutics	Pair Corr
0.85	VRDN	Viridian Therapeutics	Pair Corr
0.78	VRNA	Verona Pharma PLC	Pair Corr
0.75	VSTM	Verastem	Pair Corr

Moving against Mersana Stock

0.88	VALN	Valneva SE ADR	Pair Corr
0.57	VCNX	Vaccinex	Pair Corr
0.53	ME	23Andme Holding	Pair Corr
0.52	DRMA	Dermata Therapeutics	Pair Corr
0.5	DTIL	Precision BioSciences	Pair Corr
0.85	VRCA	Verrica Pharmaceuticals	Pair Corr
0.72	VTGN	VistaGen Therapeutics	Pair Corr
0.7	VIRX	Viracta Therapeutics	Pair Corr
0.66	DYAI	Dyadic International	Pair Corr
0.64	EDSA	Edesa Biotech Fiscal Year End 20th of December 2024	Pair Corr
0.63	CDTTW	Conduit Pharmaceuticals	Pair Corr
0.62	VINC	Vincerx Pharma	Pair Corr
0.6	VRAX	Virax Biolabs Group	Pair Corr
0.57	VRPX	Virpax Pharmaceuticals	Pair Corr
0.54	EDIT	Editas Medicine	Pair Corr
0.43	VXRT	Vaxart Inc	Pair Corr
0.4	VTVT	vTv Therapeutics Trending	Pair Corr
0.31	SRZNW	Surrozen Warrant	Pair Corr

Related Correlations Analysis

	TERN	AMLX	ABOS	INZY	XFOR	DAWN	HOOK	THRX	CGEM	RLAY
TERN		-0.47	-0.4	0.62	0.58	-0.27	0.45	0.2	0.42	0.83	TERN
AMLX	-0.47		0.57	-0.7	-0.66	0.79	-0.82	-0.69	-0.67	-0.6	AMLX
ABOS	-0.4	0.57		-0.43	-0.05	0.59	-0.11	-0.33	-0.07	-0.32	ABOS
INZY	0.62	-0.7	-0.43		0.53	-0.54	0.61	0.69	0.57	0.65	INZY
XFOR	0.58	-0.66	-0.05	0.53		-0.3	0.81	0.33	0.73	0.63	XFOR
DAWN	-0.27	0.79	0.59	-0.54	-0.3		-0.49	-0.67	-0.29	-0.32	DAWN
HOOK	0.45	-0.82	-0.11	0.61	0.81	-0.49		0.61	0.86	0.61	HOOK
THRX	0.2	-0.69	-0.33	0.69	0.33	-0.67	0.61		0.49	0.35	THRX
CGEM	0.42	-0.67	-0.07	0.57	0.73	-0.29	0.86	0.49		0.56	CGEM
RLAY	0.83	-0.6	-0.32	0.65	0.63	-0.32	0.61	0.35	0.56		RLAY
	TERN	AMLX	ABOS	INZY	XFOR	DAWN	HOOK	THRX	CGEM	RLAY

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CGEM	+ 0.86	HOOK
RLAY	+ 0.83	TERN
HOOK	+ 0.81	XFOR
DAWN	+ 0.79	AMLX
CGEM	+ 0.73	XFOR
THRX	+ 0.69	INZY

High negative correlations

HOOK	- 0.82	AMLX
INZY	- 0.7	AMLX
THRX	- 0.69	AMLX
THRX	- 0.67	DAWN
CGEM	- 0.67	AMLX
XFOR	- 0.66	AMLX

Risk-Adjusted Indicators

There is a big difference between Mersana Stock performing well and Mersana Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mersana Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TERN	3.54	(0.04)	0.00	0.10	3.80	(4.31)	7.89	(5.96)	34.09
AMLX	4.05	1.29	0.27	1.23	3.94	(4.79)	9.49	(6.13)	33.18
ABOS	3.39	(0.25)	0.00	0.05	4.31	(4.02)	7.67	(5.59)	28.07
INZY	2.59	(0.61)	0.00	(0.19)	0.00	0.00	6.11	(5.60)	16.25
XFOR	4.77	(0.25)	0.00	(0.03)	0.00	0.00	6.90	(10.61)	63.65
DAWN	2.05	(0.02)	0.00	0.11	2.45	(2.07)	3.84	(3.66)	11.17
HOOK	2.50	(0.79)	0.00	(0.37)	0.00	0.00	4.05	(5.58)	13.12
THRX	5.44	0.19	0.00	0.10	0.00	0.00	11.75	(8.57)	90.33
CGEM	2.70	(0.31)	0.00	(0.02)	0.00	0.00	6.13	(5.68)	15.67
RLAY	3.64	(0.51)	(0.03)	0.00	3.99	(4.64)	5.04	(6.29)	66.18

Mersana Therapeutics Corporate Management

Chuck Miller	Senior Affairs	Profile
Carla Poulson	Chief Officer	Profile
Marc Damelin	Oncology, Biology	Profile
Jason Fredette	Senior Communications	Profile
Mohan Bala	Senior Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC